News Focus
News Focus
Followers 260
Posts 32965
Boards Moderated 1
Alias Born 05/30/2012

Re: Monroe1 post# 236645

Monday, 05/04/2026 11:54:58 PM

Monday, May 04, 2026 11:54:58 PM

Post# of 236664
Here now looking forward ... new patent.
Go to Livimmune
r/Livimmune

11h ago
IAMLOCOTOO
New Patent Approved

From Hangout (MJS719)

docket: 230042.429

USPC new status: patented
case date of new status: 04/29/2026

The new status reflects the last status in public patent application information retrieval (pair) as of 11:59 p.m. et on the date noted above.
The patent application 17/631,161, titled "Methods for treating metastatic colon cancer with leronlimab," has officially transitioned from "pending" to "patented" as of April 29, 2026.

This change signifies that the United States Patent and Trademark Office (USPTO) has concluded its examination, found the claims to be novel and non-obvious, and granted the legal rights for the described treatment methods to CytoDyn Inc..

Key Details of the Change:
New Legal Status: Patented (formerly Pending).
Effective Date: April 29, 2026.

Scope of Protection: The patent covers specific methods of using leronlimab (a humanized CCR5-targeting monoclonal antibody) to treat patients with metastatic colorectal cancer (mCRC).Clinical Context: This grant coincides with recent clinical progress. In April 2026, CytoDyn reported early Phase 2 data showing that leronlimab, in combination with TAS-102 and bevacizumab, demonstrated biomarker activity and potential to modulate the tumor microenvironment in heavily pretreated mCRC patients.

Significance of the Grant
By moving to "patented" status, the company now holds enforceable rights to prevent others from using, selling, or importing the specific therapeutic methods claimed in the application for the duration of the patent's term. This is a critical milestone for the commercial protection of the CLOVER clinical trial regimen (leronlimab + oral chemotherapy + VEGF inhibitor).

Source: https://investorshangout.com/post/view?id=6827876
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News